Publication:
Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro

dc.contributor.authorKaçar, Ömer
dc.contributor.authorAdıgüzel, Zelal
dc.contributor.authorAçılan, Ceyda
dc.contributor.buuauthorCevatemre, Buse
dc.contributor.buuauthorArı, Ferda
dc.contributor.buuauthorSarımahmut, Mehmet
dc.contributor.buuauthorOral, Arzu Yılmaztepe
dc.contributor.buuauthorDere, Egemen
dc.contributor.buuauthorUlukaya, Engin
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFen Edebiyat Fakültesi
dc.contributor.departmentBiyokimya Ana Bilim Dalı
dc.contributor.departmentBiyoloji Bölümü
dc.contributor.orcid0000-0002-6729-7908
dc.contributor.orcid0000-0003-0463-6818
dc.contributor.researcheridAAG-7012-2021
dc.contributor.researcheridAHD-2050-2022
dc.contributor.researcheridAAH-5068-2021
dc.contributor.researcheridK-5792-2018
dc.contributor.researcheridA-5841-2017
dc.contributor.scopusid55693788600
dc.contributor.scopusid2437608530
dc.contributor.scopusid44661687400
dc.contributor.scopusid23091316500
dc.contributor.scopusid6603627015
dc.contributor.scopusid6602927353
dc.date.accessioned2022-12-05T07:13:09Z
dc.date.available2022-12-05T07:13:09Z
dc.date.issued2013-07
dc.description.abstractThe outcome in patients with breast cancer is not satisfactory to date, although new chemotherapy regimens have been introduced in clinics. Therefore, novel approaches are required for better management of patients with breast cancer. In this study, we tested the cytotoxic activity of a new combination of fenretinide, a synthetic retinoid, with indole-3-carbinol, a natural product present in vegetables such as broccoli and cabbage, against MCF-7 (estrogen receptor-positive) and MDA-MB-231 (estrogen receptor-negative) cell lines. It has been found that the combination resulted in more powerful cytotoxic activity, by induction of apoptosis, compared with that when they were used singly. In conclusion, this novel combination warrants in-vivo experiments to elucidate its possible use in the treatment of breast cancer.
dc.identifier.citationCevatemre, B. vd. (2013). ''Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro". Anti-Cancer Drugs, 24(6), 577-586.
dc.identifier.endpage586
dc.identifier.issn0959-4973
dc.identifier.issn1473-5741
dc.identifier.issue6
dc.identifier.pubmed23542749
dc.identifier.scopus2-s2.0-84878902921
dc.identifier.startpage577
dc.identifier.urihttps://doi.org/10.1097/CAD.0b013e328360a921
dc.identifier.urihttps://journals.lww.com/anti-cancerdrugs/Fulltext/2013/07000/Combination_of_fenretinide_and_indole_3_carbinol.4.aspx
dc.identifier.urihttp://hdl.handle.net/11452/29660
dc.identifier.volume24
dc.identifier.wos000323214000004
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.bapUAP(F)-2011/44
dc.relation.collaborationSanayi
dc.relation.journalAnti-Cancer Drugs
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectPharmacology & pharmacy
dc.subject3,3 '-diindolylmethane
dc.subjectBreast cancer
dc.subjectChemotherapy
dc.subjectCytotoxicity
dc.subjectFenretinide (4-HPR)
dc.subjectIndole-3-carbinol
dc.subjectGene-expression
dc.subjectDown-regulation
dc.subjectOvarian-cancer
dc.subjectCycle arrest
dc.subjectGrowth
dc.subject3,3'-diindolylmethane
dc.subjectDeath
dc.subjectInduction
dc.subject3,3-diindolylmethane
dc.subjectInhibition
dc.subject.emtree3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide
dc.subject.emtree3 indolemethanol
dc.subject.emtreeAdenosine triphosphate
dc.subject.emtreeFenretinide
dc.subject.emtreeApoptosis
dc.subject.emtreeArticle
dc.subject.emtreeBreast cancer
dc.subject.emtreeBroccoli
dc.subject.emtreeCabbage
dc.subject.emtreeCell death
dc.subject.emtreeCell viability
dc.subject.emtreeControlled study
dc.subject.emtreeDrug cytotoxicity
dc.subject.emtreeEstrogen receptor positive breast cancer
dc.subject.emtreeFluorescence imaging
dc.subject.emtreeGene expression
dc.subject.emtreeGenetic transfection
dc.subject.emtreeHuman
dc.subject.emtreeHuman cell
dc.subject.emtreeIn vitro study
dc.subject.emtreePriority journal
dc.subject.emtreeWestern blotting
dc.subject.meshAntineoplastic agents
dc.subject.meshApoptosis
dc.subject.meshCell cycle
dc.subject.meshDNA, complementary
dc.subject.meshDrug synergism
dc.subject.meshFenretinide
dc.subject.meshGene expression regulation, neoplastic
dc.subject.meshHumans
dc.subject.meshIndoles
dc.subject.meshMCF-7 cells
dc.subject.meshRNA
dc.subject.meshRNA, small interfering
dc.subject.meshTransfection
dc.subject.scopus3 Indolemethanol; Indoles; 3-(2-Bromoethyl)Indole
dc.subject.wosOncology
dc.subject.wosPharmacology & pharmacy
dc.titleCombination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro
dc.typeArticle
dc.wos.quartileQ3
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentFen Edebiyat Fakültesi/Biyoloji Bölümü
local.contributor.departmentTıp Fakültesi/Biyokimya Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: